( Reuters)-The European Union’s medicine controller on Tuesday expressed dubieties about the need for a fourth supporter cure of COVID-19 vaccine and said there’s presently no data to support this approach as it seeks further data on the fast- spreading Omicron variant.
“While use of fresh boosters can be part of contingency plans, repeated vaccinations within short intervals would not represent a sustainable long- term strategy,”the European Medicines Agency’s Head of Vaccines Strategy, Marco Cavaleri, told a media briefing.
The EMA functionary raised enterprises that a strategy of giving boosters every four months hypothetically poses the threat of overfilling people’s vulnerable systems and leading to fatigue in the population.
Cavaleri also said more data on the impact of the new variant on vaccines and a better understanding of the elaboration of the current surge were demanded to decide whether an Omicron-specific vaccine was demanded.
“It’s important that there’s a good discussion around the choice of the composition of the vaccine to make sure that we’ve a strategy that isn’t just reactive. and try to come up with an approach that will be suitable in order to help a unborn variant,”he said.
The EMA said it was presently in discussion with vaccine inventors in case there’s a need for an streamlined vaccine but added that any similar change would need to be coordinated encyclopedically.